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Other names: LAZ3 ( Lymphoma Associated Zinc 
finger on chromosome 3); ZNF51 (Zinc Finger Protein 
51) 
Location: 3q27 




BCL6 (3q27) - Courtesy Mariano Rocchi, Resources for 
Molecular Cytogenetics. Laboratories willing to validate the 
probes are welcome : contact rocchi@biologia.uniba.it. 
DNA/RNA 
Description 
The gene is encoded by 11 exons that are located on 
Chromosome 3q27 and is 24.3 kb. The 5’ portion 
encodes for the BTB/POZ domain (broad-
complex/tramtrack/bric-a-brac/pox virus/zinc finger), 
while the 3’ end encodes for 6 DNA binding zinc 
fingers. The first ATG occurs in exon 3. 
Transcription 
3.8 kb mRNA. 
Protein 
Description 
The protein product is 706 amino acids with an 
estimated molecular weight of 78.8 kDa. 
Expression 
Normally expressed in germinal center B and T cells, 





The protein can bind to sequence specific DNA and 
repress its transcription in addition to recruiting other 
protein repressors. The DNA binding is mediated 
through the consensus sequence: TTCCT(A/C)GAA 
while the protein-protein interactions are mediated 
through the BTB/POZ domain and it has been shown to 
interact with other zinc finger proteins and corepressors 
(including Histone Deacetylase 1 (HDAC1) and 
Silencing Mediator of Retinoid and Thryoid Receptor 1 
(SMRT1)). The carboxy terminus, on the other hand, is 
responsible for sequence specific DNA binding through 
its 6 zinc fingers. 
Homology 
BTB/POZ - Zinc Finger proteins (PLZF, HIC1, KUP, 
BAZF, ttk (drosophila), BrC (drosophila)...). 










3q27 rearrangements /NHL (non 
Hodgkin lymphomas) 
Disease 
B cell non-Hodgkin Lymphoma (B-NHL) carry the 
greatest number of translocations involving the BCL6 
gene locus. Translocations are most commonly 
detected within 15-40% of Diffuse Large B-Cell 
Lymphomas (DLBCL), 6-15% of Follicular 
Lymphomas (FL), and 50% of nodular lymphocyte 
predominant Hodgkin Lymphomas. 
Prognosis 
Generally considered to be a better prognosis if there is 
increased expression of BCL6. The mechanism by 
which its expression is increased does not seem to 
matter (ie different translocation partners increasing its 
expression results in the same prognosis). 
Cytogenetics 
3q27 rearrangements/aberrations are diverse and 
include: translocations, micro-deletions, point 
mutations and hypermutation. Approximately 50% of 
3q27 translocations involves Ig genes at 14q32 (IgH), 
2p12 (IgK) and 22q12 (IgL) (e.g. t(3;14)(q27;q32). 
Less than half (~40%) include a variety of other 
chromosomal regions (1q21, 2q21, 4p11, 5q31, 6p21, 
7p12, 8q24, 9p13, 11q13, 11q23, 12q11, 13q14-21, 
14q11, 15q21, 16p11...). In addition, there are frequent 
bi-allelic alterations (translocation and deletion or
mutation on the non-translocated allele). 
Hybrid/Mutated Gene 
Hybrid gene and transcripts are formed following 
promoter substitution between BCL6 and its different 
partners. Chimeric transcripts are generally detectd 
containing the 5' part of the gene partner fused to the 
normal BCL6 exon 2 splice acceptor site. In some cases 
reciprocal chimeric transcripts driven by the 5' 
regulatory region of BCL6 fused to the partner gene 
coding region, have been characterised. 
t(2;3)(p12;q27) the gene in 2p12 is IGK 
t(3;3)(q25;q27) the gene in 3q25 is MBNL1 
t(3;3)(q27;q27) the gene in 3q27 is ST6GAL1 
t(3;3)(q27;q27) the gene in 3q27 is EIF4A2 
t(3;3)(q27;q29) the gene in 3q29 is TFRC 
t(3;4)(q27;p13) the gene in 4p13 is RHOH 
t(3;6)(q27;p22) the gene in 6p22 is HIST1H4I 
t(3;6)(q27;p21) the gene in 6p21 is PIM1 
t(3;6)(q27;p21) the gene in 6p21 is SFRS3 
t(3;6)(q27;p21) the gene in 6p21 is Histone H4 
t(3;6)(q27;p12) the gene in 6p12 is HSP90AB1 
t(3;6)(q27;q15) the gene in 6q15 is SNHG5 
t(3;7)(q27;p12) the gene in 7p12 is IKZF1 
t(3;8)(q27;q24.1) the gene in 8q24.1 is MYC 
t(3;9)(q27;p11) the gene in 9p11 is GRHPR 
t(3;11)(q27;q23) the gene in 11q23 is POU2AF1 
t(3;12)(q27;p13) the gene in 12p13 is GAPDH 
t(3;12)(q27;q12) the gene in 12q12 is LRMP 
t(3;12)(q27;q23) the gene in 12q23 is NACA 
t(3;13)(q27;q14) the gene in 13q14 is LCP1 
t(3;14)(q27;q32) the gene in 14q32 is IGH 
t(3;14)(q27;q32) the gene in 14q32 is HSP90AA1 
t(3;16)(q27;p13) the gene in 16p13 is CIITA 
t(3;16)(q27;p11) the gene in 16p11 is IL21R 
t(3;19)(q27;q13) the gene in 19q13 is NAPA 
t(3;22)(q27;q11) the gene in 22q11 is IGL 
Abnormal Protein 
No fusion protein. 
Breakpoints 
Note: Clustered in a 3,3kb EcoRI fragment (MTC) 
includind exon 1A and intron 1. 
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